Induced Pluripotent Stem Cells Meet Genome Editing

Hockemeyer, Dirk, Jaenisch, Rudolf·2016·Cell Stem Cell

Cited by (500)

Items 101–200 of 500

  1. Urine-derived stem/progenitor cells: A focus on their characterization and potential
    Perrine Burdeyron, Sébastien Giraud, Thierry Hauet, Clara Steichen · 2020 · World Journal of Stem Cells
  2. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
    Sandy S. C. Hung, Shahnaz Khan, Camden Yeung-Wah Lo, Alex William Hewitt, Raymond C.B. Wong · 2017 · Pharmacology & Therapeutics
  3. Current advances in primate genomics: novel approaches for understanding evolution and disease
    David Juan, Gabriel Santpere, Joanna L. Kelley, Omar E. Cornejo, Tomàs Marquès‐Bonet · 2023 · Nature Reviews Genetics
  4. Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Fit for Purpose or Forever Elusive?
    Tessa de Korte, Puspita Anggraini Katili, Nurul Ain Nasim Mohd Yusof, Berend J. van Meer, Umber Saleem, Francis L. Burton, Godfrey L. Smith, Peter Clements, Christine L. Mummery, Thomas Eschenhagen A et al. · 2019 · The Annual Review of Pharmacology and Toxicology
  5. Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity
    Sapp, Valerie, Aguirre, Aitor, Mainkar, Gayatri, Ding, Jeffrey, Adler, Eric, Liao, Ronglih, Sharma, Sonia, Jain, Mohit · 2021 · Scientific Reports
  6. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
    Eric K. N. Gähwiler, Sarah E. Motta, Marcy Martin, Bramasta Nugraha, Simon Philipp Hoerstrup, Maximilian Y. Emmert · 2021 · Frontiers in Cell and Developmental Biology
  7. Induced pluripotent stem cells, past and future
    Eirini P. Papapetrou · 2016 · Science
  8. Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection
    Katie A. Mitzelfelt, Chris McDermott‐Roe, Michael N. Grzybowski, Maribel Marquez, Chieh-Ti Kuo, Michael J Riedel, Shuping Lai, Melinda J. Choi, Kurt D. Kolander, Daniel C. Helbling et al. · 2017 · Stem Cell Reports
  9. The erythroblastic island niche: modeling in health, stress, and disease
    Alisha May, Lesley M. Forrester · 2020 · Experimental Hematology
  10. Biohybrid neural interfaces: improving the biological integration of neural implants
    Marjolaine Boulingre, Roberto Portillo Lara, Rylie A. Green · 2023 · Chemical Communications
  11. Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering
    Martijn F. Hoes, Nils Bömer, Peter van der Meer · 2018 · Stem Cells Translational Medicine
  12. Modeling genetic epilepsies in a dish
    Wei Niu, Jack M. Parent · 2019 · Developmental Dynamics
  13. Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses
    Hisashi Akiyama, Sallieu Jalloh, Seonmi Park, Maohua Lei, Gustavo Mostoslavsky, Suryaram Gummuluru · 2020 · Journal of Virology
  14. Long-term morphological and functional dynamics of human stem cell-derived neuronal networks on high-density micro-electrode arrays
    Rouhollah Habibey, Johannes Striebel, Felix Schmieder, Jürgen W. Czarske, Volker Busskamp · 2022 · Frontiers in Neuroscience
  15. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
    Chia-Yu Chang, Hsiao-Chien Ting, Hong‐Lin Su, Jing‐Ren Jeng · 2018 · Cell Transplantation
  16. Macrophages derived from pluripotent stem cells: prospective applications and research gaps
    Irina V. Lyadova, Andrey Valentinovich Vasiliev · 2022 · Cell & Bioscience
  17. Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress
    Šárka Jelínková, Petr Fojtík, Aneta Kohutová, Aleksandra Vilotić, Lenka Marková, Martin Pešl, Tereza Juráková, Miriama Krutá, Jan Vrbský, Renata Gaillyová et al. · 2019 · Cells
  18. New frontiers in modeling tuberous sclerosis with human stem cell‐derived neurons and brain organoids
    John D. Blair, Helen S. Bateup · 2019 · Developmental Dynamics
  19. Genomic integrity of human induced pluripotent stem cells: Reprogramming, differentiation and applications
    Clara Steichen, Zara Hannoun, Eléanor Luce, Thierry Hauet, Anne Dubart‐Kupperschmitt · 2019 · World Journal of Stem Cells
  20. Adenoviral Vectors Meet Gene Editing: A Rising Partnership for the Genomic Engineering of Human Stem Cells and Their Progeny
    Francesca Tasca, Qian Wang, Manuel A.F.V. Gonçalves · 2020 · Cells
  21. Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
    K. Verhoeff, Sarah Henschke, B. Marfil-Garza, Nidheesh Dadheech, A. M. Shapiro · 2021 · Cells
  22. CRISPR/Cas9-mediated one step bi-allelic change of genomic DNA in iPSCs and human RPE cells in vitro with dual antibiotic selection
    Wasu Supharattanasitthi, Emil Carlsson, Umar Sharif, Luminita Paraoan · 2019 · Scientific Reports
  23. 3D kidney organoids for bench-to-bedside translation
    Navin R. Gupta, Emre Dilmen, Ryuji Morizane · 2020 · Journal of Molecular Medicine
  24. Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
    Hui Ping Lin, Kim L. McBride, Vidu Garg, Mingtao Zhao · 2021 · Frontiers in Cell and Developmental Biology
  25. Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss
    Miodrag Stojković, Dongjun Han, Minjin Jeong, Petra Stojković, Konstantina M. Stanković · 2021 · Stem Cells
  26. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs
    Jeong Sang Son, Chul‐Yong Park, Gyunggyu Lee, Ji Young Park, Hyo Jin Kim, Gyeongmin Kim, Kyun Yoo Chi, Dong‐Hun Woo, Choongseong Han, Sang Kyum Kim et al. · 2022 · Biomaterials
  27. Systems-Wide Approaches in Induced Pluripotent Stem Cell Models
    Edward Lau, David T. Paik, Joseph C. Wu · 2018 · Annual Review of Pathology Mechanisms of Disease
  28. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology
    Jihoon Kim, Bon‐Kyoung Koo, Ki‐Jun Yoon · 2019 · Viruses
  29. Induced Pluripotency: A Powerful Tool for In Vitro Modeling
    Romana Záhumenská, Vladimír Nosáľ, Marek Smolár, Terézia Okajčeková, Henrieta Škovierová, Ján Strnádel, Erika Halášová · 2020 · International Journal of Molecular Sciences
  30. Modeling fibrotic alveolar transitional cells with pluripotent stem cell-derived alveolar organoids
    Victoria Ptasinski, Susan J. Monkley, Karolina Öst, Markus Tammia, Hani N. Alsafadi, Catherine L. Overed-Sayer, Petra Hazon, Darcy Elizabeth Wagner, Lynne A. Murray · 2023 · Life Science Alliance
  31. Studying the Brain in a Dish: 3D Cell Culture Models of Human Brain Development and Disease
    Juliana R. Brown, Giorgia Quadrato, Paola Arlotta · 2018 · Current topics in developmental biology/Current Topics in Developmental Biology
  32. Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia
    Shabeesh Balan, Manabu Toyoshima, Takeo Yoshikawa · 2018 · Neurobiology of Disease
  33. Modeling blood diseases with human induced pluripotent stem cells
    Maria Georgomanoli, Eirini P. Papapetrou · 2019 · Disease Models & Mechanisms
  34. Biophysical Psychiatry—How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders
    Tuomo Mäki‐Marttunen, Tobias Kaufmann, Torbjørn Elvsåshagen, Anna Devor, Srdjan Djurovic, Lars Tjelta Westlye, Marja‐Leena Linne, Marcella Rietschel, Dirk Schubert, Stefan Borgwardt et al. · 2019 · Frontiers in Psychiatry
  35. Science Runs and the Debate Brakes: Somatic Gene-Editing as a New Tool for Gender-Specific Medicine in Alzheimer’s Disease
    Pamela Tozzo, Silvia Zullo, Luciana Caenazzo · 2020 · Brain Sciences
  36. Versatile Roles of the Chromatin Remodeler CHD7 during Brain Development and Disease
    Weijun Feng, Chunxuan Shao, Hai‐Kun Liu · 2017 · Frontiers in Molecular Neuroscience
  37. Implications for a Stem Cell Regenerative Medicine Based Approach to Human Intervertebral Disk Degeneration
    Petra Kraus, Thomas Lufkin · 2017 · Frontiers in Cell and Developmental Biology
  38. Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
    Jin Jea Sung, Chul‐Yong Park, Joong Woo Leem, Myung Soo Cho, Dong‐Wook Kim · 2019 · Experimental & Molecular Medicine
  39. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models
    Jessica L. Forbester, Mathew Clement, Dannielle Wellington, Amy T. Y. Yeung, Sandra Dimonte, Morgan Marsden, Lucy Chapman, Eve L. Coomber, Charlotte Tolley, Emily A. Lees et al. · 2020 · Journal of Virology
  40. Embryo-mediated genome editing for accelerated genetic improvement of livestock
    Zachariah L. McLean, Björn J. Oback, Götz Laible · 2020 · Frontiers of Agricultural Science and Engineering
  41. Induced Pluripotent Stem Cells for Ischemic Stroke Treatment
    Ranran Duan, Yang Gao, Ruya He, Li-Jun Jing, Yan-Fei Li, Z. Gong, Yao-Bing Yao, Tingting Luan, Chao-Peng Zhang, Li Li et al. · 2021 · Frontiers in Neuroscience
  42. Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
    Shin Yi Tang, Shijun Zha, Zhicheng Du, Jieming Zeng, Detu Zhu, Yumei Luo, Shu Wang · 2021 · Stem Cell Research & Therapy
  43. Recent advances for using human induced-pluripotent stem cells as pain-in-a-dish models of neuropathic pain
    Julie I. R. Labau, Mirna Anđelić, Catharina Gerritdina Faber, Stephen G. Waxman, Giuseppe Lauria, Sulayman D. Dib‐Hajj · 2022 · Experimental Neurology
  44. Highly Efficient CRISPR‐Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells
    Jean Ann Maguire, Fabian L. Cardenas‐Diaz, Paul J. Gadue, Deborah L. French · 2018 · Current Protocols in Stem Cell Biology
  45. Use of Human Pluripotent Stem Cell-Derived Cells for Neurodegenerative Disease Modeling and Drug Screening Platform
    Juan Antonio García‐León, Javier Vitórica, Antonia Gutiérrez · 2019 · Future Medicinal Chemistry
  46. HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
    Hisashi Akiyama, Suryaram Gummuluru · 2020 · Viruses
  47. Using induced pluripotent stem cells to understand retinal ciliopathy disease mechanisms and develop therapies
    David A. Parfitt, Amelia Lane, Conor M. Ramsden, Katarina Jovanovic, Peter J. Coffey, Alison J. Hardcastle, Michael E. Cheetham · 2016 · Biochemical Society Transactions
  48. Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance
    Keun-Tae Kim, Ju-Chan Park, Hyeon‐Ki Jang, Haeseung Lee, Seokwoo Park, Jumee Kim, Ok‐Seon Kwon, Young-Hyun Go, Yan Jin, Wankyu Kim et al. · 2020 · Biomaterials
  49. Big-Data-Driven Stem Cell Science and Tissue Engineering: Vision and Unique Opportunities
    Antonio del Sol, H.-J. Thiesen, Jaime Imitola, Rafael E. Carazo Salas · 2017 · Cell stem cell
  50. Generation and Characterization of Functional Human Hypothalamic Neurons
    Peter Kirwan, Magdalena Jura, Florian T. Merkle · 2017 · Current Protocols in Neuroscience
  51. Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine
    Joffrey Mianné, Engi Ahmed, Chloé Bourguignon, Mathieu Fieldès, Isabelle Vachier, ARNAUD AB BOURDIN, Saïd Assou, John De Vos · 2018 · American Journal of Respiratory Cell and Molecular Biology
  52. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system
    Munenari Itoh, Shiho Kawagoe, Katsuto Tamai, Hidemi Nakagawa, Akihiko Asahina, Hirotaka James Okano · 2020 · Journal of Dermatological Science
  53. The microbiota‐gut‐brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models
    Federica Fusco, Simone Perottoni, Carmen Giordano, Antonella Riva, Luigi Francesco Iannone, Carmen De Caro, Emilio Russo, Diego Albani, Pasquale Striano · 2022 · Bioengineering & Translational Medicine
  54. Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9
    Chul‐Yong Park, Jin Jea Sung, Sang-Hwi Choi, Dongjin R. Lee, In‐Hyun Park, Dong‐Wook Kim · 2016 · Nature Protocols
  55. CRISPR/Cas9 Editing for Gaucher Disease Modelling
    Eleonora Pavan, Maximiliano Ormazábal, Paolo Peruzzo, Emilio Vaena, Paula Adriana Rozenfeld, Andrea Dardis · 2020 · International Journal of Molecular Sciences
  56. Stem Cell Therapy for Repair of the Injured Brain: Five Principles
    Ruslan Rust, Christian Tackenberg · 2022 · The Neuroscientist
  57. Induced pluripotent stem cell-based modeling of neurodegenerative diseases: a focus on autophagy
    Johannes Jungverdorben, Andreas Till, Oliver Brüstle · 2017 · Journal of Molecular Medicine
  58. CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles
    Joffrey Mianné, Amel Nasri, Chloé Nguyen Van, Chloé Bourguignon, Mathieu Fieldès, Engi Ahmed, Christine T Duthoit, Nicolas Martin, Hugues Parrinello, Anaïs Louis et al. · 2022 · BMC Biology
  59. Small Extracellular Vesicles Derived from Induced Pluripotent Stem Cells in the Treatment of Myocardial Injury
    Wanting Meng, Hai-Dong Guo · 2023 · International Journal of Molecular Sciences
  60. HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs
    Jianping Zhang, Zhi-Xue Yang, Feng Zhang, Ya-Wen Fu, Xinyue Dai, Wei Wen, Beldon Zhang, Hannah Choi, Wanqiu Chen, Meredith Brown et al. · 2021 · Science China Life Sciences
  61. Context-Responsive Nanoparticle Derived from Synthetic Zwitterionic Ionizable Phospholipids in Targeted CRISPR/Cas9 Therapy for Basal-like Breast Cancer
    Parikshit Moitra, David Skrodzki, Matthew Molinaro, Nivetha Gunaseelan, Dinabandhu Sar, Teresa Aditya, Dipendra Dahal, Priyanka Ray, Dipanjan Pan · 2024 · ACS Nano
  62. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
    Sarah Logan, Thiago Arzua, Scott Glen Canfield, Emily R. Seminary, Samantha L. Sison, Allison D. Ebert, Xiaowen Bai · 2019 · Comprehensive physiology
  63. Induced pluripotent stem cells for treating cystic fibrosis: State of the science
    Bette S. Pollard, Harvey B. Pollard · 2018 · Pediatric Pulmonology
  64. Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
    Desiree Piper, Danuta Sastre, Birgitt Schüle · 2018 · Frontiers in Neuroscience
  65. p53 activation: a checkpoint for precision genome editing?
    Anastasia Conti, Raffaella Di Micco · 2018 · Genome Medicine
  66. Human stem cell‐based models for studying host‐pathogen interactions
    Enrica Pellegrino, M. Gutierrez · 2021 · Cellular Microbiology
  67. Genome Editing in Neurosciences
    Rudolf Jaenisch, Fred H. Gage, Feng Zhang · 2017 · Research and perspectives in neurosciences
  68. Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease
    Nathaniel K. Mullin, A. Voigt, J. Cooke, L. Bohrer, Erin R. Burnight, E. Stone, R. Mullins, B. Tucker · 2020 · Progress in retinal and eye research
  69. Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy
    Marko Ušaj, Luisa Moretto, Alf Månsson · 2022 · International Journal of Molecular Sciences
  70. Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
    Louise Reilly, Saba Munawar, Jianhua Zhang, Wendy C. Crone, Lee L. Eckhardt · 2022 · Frontiers in Cardiovascular Medicine
  71. Cell-based mechanisms and strategies of co-culture system both in vivo and vitro for bone tissue engineering
    Mengning Bi, Kaiwen Yang, Tao Yu, Gang Wu, Qiong Li · 2023 · Biomedicine & Pharmacotherapy
  72. The potential of induced pluripotent stem cells as a tool to study skeletal dysplasias and cartilage-related pathologic conditions
    Huan Liu, L. Yang, Fuxun Yu, Shijie Wang, Cuiyan Wu, Chengjuan Qu, Mikko Juhani Lammi, X. Guo · 2016 · Osteoarthritis and Cartilage
  73. Modeling myeloid malignancies with patient-derived iPSCs
    Eirini P. Papapetrou · 2018 · Experimental Hematology
  74. An update on stem cells applications in burn wound healing
    Sana Ullah, Sumaiya Mansoor, Aaima Ayub, Momina Ejaz, Hajrah Zafar, Fizza Feroz, Ayyaz Khan, Muhammad Ali · 2021 · Tissue and Cell
  75. Micro/nanoengineered technologies for human pluripotent stem cells maintenance and differentiation
    Sajedeh Nasr Esfahani, Agnes M. Resto Irizarry, Xufeng Xue, Samuel Byung-Deuk Lee, Yue Shao, Jianping Fu · 2021 · Nano Today
  76. Stem Cell Therapy in Treating Epilepsy
    Bao‐Luen Chang, Kuo‐Hsuan Chang · 2022 · Frontiers in Neuroscience
  77. Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine
    Nozomu Takata, Mototsugu Eiraku · 2017 · Journal of Human Genetics
  78. On the Viability and Potential Value of Stem Cells for Repair and Treatment of Central Neurotrauma: Overview and Speculations
    Samantha Wu, K. Fitzgerald, J. Giordano · 2018 · Frontiers in Neurology
  79. Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
    Carles Calatayud, Giulia Carola, Antonella Consiglio, Ángel Raya · 2017 · Current Opinion in Genetics & Development
  80. Cardiomyocyte Death and Genome-Edited Stem Cell Therapy for Ischemic Heart Disease
    Hyunmin Cho, Je‐Yoel Cho · 2021 · Stem Cell Reviews and Reports
  81. Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9
    Amanda Haupt, Tanya Grancharova, Joy Arakaki, Margaret A. Fuqua, Brock Roberts, Ruwanthi N. Gunawardane · 2018 · Journal of Visualized Experiments
  82. Stem cells: A path towards improved epilepsy therapies
    Zane R. Lybrand, Sonal Goswami, Jenny Hsieh · 2019 · Neuropharmacology
  83. Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
    Toshio Nakanishi, H. Scott Baldwin, Jeffrey R. Fineman, Hiroyuki Yamagishi · 2020 · Springer eBooks
  84. Deciphering the physiopathology of neurodevelopmental disorders using brain organoids
    Olivier Dionne, Salomé Sabatié, Benoît Laurent · 2024 · Brain
  85. Genetically engineered human induced pluripotent stem cells for the production of brain-targeting extracellular vesicles
    Fan Tang, Tao Dong, Chengqian Zhou, Leon Deng, Hans B. Liu, Wenshen Wang, Guanshu Liu, Mingyao Ying, Pan P. Li · 2024 · Stem Cell Research & Therapy
  86. Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
    Yong Hui Koh, Li Yi Tan, Shi‐Yan Ng · 2018 · Frontiers in Cellular Neuroscience
  87. 3D Bioprinting for fabrication of tissue models of COVID-19 infection
    Anisha Kabir, Pallab Datta, Julia Oh, Adam Williams, Veli Özbolat, Derya Unutmaz, Ibrahim Tarik Ozbolat · 2021 · Essays in Biochemistry
  88. Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury
    Jun Li, Ying-Li Jing, Fan Bai, Ying Wu, Limiao Wang, Yitong Yan, Yunxiao Jia, Yan Yu, Benzhi Jia, Fawad Ali · 2023 · Frontiers in Pharmacology
  89. The promise of induced pluripotent stem cells for neurodevelopmental disorders
    Katrin Linda, Carol Fiuza, Nael Nadif Kasri · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  90. Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy
    Elena Seranova, Adina Maria Palhegyi, Surbhi Verma, Simona Dimova, Rachel Lasry, Moriyah Naama, Congxin Sun, Timothy Geoffrey Barrett, Tatiana Rosado Rosenstock, Dhiraj Kumar et al. · 2020 · Journal of Molecular Biology
  91. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
    Ye Tao, Yangyang Duan, Hayley W. S. Tsang, He Jax Xu, Yuewen Chen, Han Cao, Yu Chen, Amy K.Y. Fu, Nancy Y. Ip · 2021 · Communications Biology
  92. Exploring digenic inheritance in arrhythmogenic cardiomyopathy
    Eva König, Cláudia B. Volpato, Benedetta Maria Motta, Hagen Blankenburg, Anne Picard, Peter Paul Pramstaller, Michela Casella, Werner Rauhe, Giulio Pompilio, Viviana Meraviglia et al. · 2017 · BMC Medical Genetics
  93. From the Psychiatrist’s Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish
    Anke Hoffmann, Vincenza Sportelli, Michael J. Ziller, Dietmar Spengler · 2018 · International Journal of Molecular Sciences
  94. CRISPR/Cas9 Edited Induced Pluripotent Stem Cell-Based Vascular Tissues to Model Aging and Disease-Dependent Impairment
    Aylin Acun, Pınar Zorlutuna · 2019 · Tissue Engineering Part A
  95. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation
    Benjamin Dannenmann, Masoud Nasri, Karl Welte, Julia Skokowa · 2020 · Methods in molecular biology
  96. A Cas9-mediated adenosine transient reporter enables enrichment of ABE-targeted cells
    Nicholas Brookhouser, Toan Nguyen, Stefan J. Tekel, Kylie Standage-Beier, Xiao Wang, David A. Brafman · 2020 · BMC Biology
  97. Directed differentiation and direct reprogramming: Applying stem cell technologies to hearing research
    Marta Roccio · 2020 · Stem Cells
  98. Xenogeneic chimera—Generated by blastocyst complementation—As a potential unlimited source of recipient‐tailored organs
    Graziano Oldani, Andrea Peloso, Stéphanie Lacotte, Raphael P. H. Meier, Christian Toso · 2017 · Xenotransplantation
  99. Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy
    Bruno Sterlini, Floriana Fruscione, Sımona Baldassari, Fabio Benfenati, Federico Zara, Anna Corradi · 2020 · International Journal of Molecular Sciences
  100. Induced Pluripotent Stem Cells (iPSCs) in Vascular Research: from Two- to Three-Dimensional Organoids
    Anja Trillhaase, Marlon Märtens, Zouhair Aherrahrou, Jeanette Erdmann · 2021 · Stem Cell Reviews and Reports